Boston

Fate’s natural killer cells induce responses in blood cancer patients – Boston, Massachusetts

Boston, Massachusetts 2021-06-04 12:18:52 –

Fate Therapeutics announced on Friday that experimental off-the-shelf immunotherapy made from so-called natural killer cells caused a complete tumor response in more than half of patients with advanced lymphoma treated in early-stage clinical trials. ..

The 56% complete response rate reported for the treatment of Fate cancer called FT516 is still provisional and has been evaluated by only 11 patients, but has been reported with other types of cell therapy. Similar to effectiveness. However, the durability of the response to the FT516 remains an important open issue.

Subscribe to STAT + to unlock this article and enjoy it for free for the first 30 days!

let’s start



Fate’s natural killer cells induce responses in blood cancer patients Source link Fate’s natural killer cells induce responses in blood cancer patients

Back to top button